Annual report pursuant to Section 13 and 15(d)

Intangible Assets (Tables)

v3.22.4
Intangible Assets (Tables)
12 Months Ended
Nov. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Intangible Assets

Intangible assets were as follows as of November 30, 2022 and 2021:

 

 

 

Useful lives

 

November 30, 2022

 

 

November 30, 2021

 

Patents

 

10-20 years

 

$

697,744

 

 

$

697,744

 

Less: Accumulated amortization

 

 

 

 

(120,297

)

 

 

(80,159

)

License agreement

 

10 years

 

 

474,000

 

 

 

474,000

 

Less: Intangible asset impairment

 

 

 

 

(185,000

)

 

 

(185,000

)

Less: Accumulated amortization

 

 

 

 

(225,157

)

 

 

(201,709

)

Customer relationships – PrepaCyte®CB

 

15 years

 

 

41,000

 

 

 

41,000

 

Less: Intangible asset impairment

 

 

 

 

(26,267

)

 

 

(26,267

)

Less: Accumulated amortization

 

 

 

 

(8,711

)

 

 

(7,916

)

Brand

 

1 year

 

 

31,000

 

 

 

31,000

 

Less: Accumulated amortization

 

 

 

 

(31,000

)

 

 

(31,000

)

Customer relationships – Cord:Use

 

30 years

 

 

960,000

 

 

 

960,000

 

Less: Accumulated amortization

 

 

 

 

(144,000

)

 

 

(112,000

)

Net Intangible Assets

 

 

 

$

1,463,312

 

 

$

1,559,693

 

Schedule of Expected Amortization Expenses

Expected amortization related to these intangible assets for each of the next five fiscal years and for periods thereafter is as follows:

 

Fiscal years ending November 30:

 

 

 

2023

 

$

96,381

 

2024

 

$

96,381

 

2025

 

$

86,694

 

2026

 

$

73,132

 

2027

 

$

73,132

 

Thereafter

 

$

1,037,592

 

Total

 

$

1,463,312